FDA
-
-
-
-
-
-
-
COYA Therapeutics founder steps down, appoints Pavao to board
-
-
-
-
-
-
-
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial
-
-
-
-
-
-
-
FDA accepts Coya Therapeutics IND for dementia treatment COYA 302
-
-
-
-
-
-
-
Coya Therapeutics closes $23 million public offering
-
-
-
-
-
-
-
Coya Therapeutics Launches the ALSTARS Trial, a Phase 2 Clinical Study to Assess the Efficacy and Safety of COYA 302 in Amyotrophic Lateral Sclerosis
-
-
-
-
-
-
-
Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Coya Therapeutics (COYA)
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

